RNA sequencing and cell thermal transfer assays indicated that Flubendazole, by reducing PCSK9 expression, inhibited PCSK9‐induced Hedgehog signaling, leading to downregulation of Smoothened (SMO) and Gli1 in HCC. Here, PCSK9 is linked to hepatocellular carcinoma.